News

After the float: Imperial Innovations

How will Imperial College London's newly floated tech-transfer affiliate invest its stock-market millions? After raising the money, now comes the fun part: spending it.

Cytokine for treating autoimmune diseases ready for partnering

PharmaLinks, a business dedicated to commercialising pharmaceutical research, is looking for a development partner for an immunosuppressive cytokine with therapeutic potential in inflammatory diseases including rheumatoid arthritis, asthma, COPD and arteriosclerosis.

Blue biotech emerges from the deep

Blue biotech is getting into its stride, as the tools of genomics and high throughput screening are applied to unlock the chemical diversity of the oceans.

The spin on electronics

It is a hard life being an electronics business, they just keep changing the science under you. This time around we have a combination of electronics and spin – and that has nothing to do with PR.

Creative Commons: Benkler and Lessig practice what they preach

Yochai Benkler and Lawrence Lessig are two well-known law professors affiliated with very prestigious US universities, Yale and Stanford, respectively. They are specialised in intellectual property like policemen are specialised in crime: it is their bailiwick but they do not particularly like it.